Home
About Us
Science
Newsroom
Careers
Contact
中文
EN
About Us
Science
Newsroom
Careers
Contact
中文
EN
Press Releases
View all
Qihan Biotech Announces NMPA Approval of Investigational New Drug (IND) Application for QN-019a, a Multi-locus Gene-Editing Cell Therapy Product to treat CD19-positive B-Cell Lymphoma
July 2023
Qihan Biotech Appoints Tony W. Ho to its Board of Directors
October 2022
Qihan Biotech today announced the appointment of Tony W. Ho, M.D., to its Board of Directors as an independent director.
Media Coverage
View all
Qihan raises $67M to advance cell and organ therapies in China
March 2021
Bioworld
Gene Editing for Transplants and Cell Therapy: Luhan Yang on the Long Run
January 2021
Timmerman Report
Luhan Yang| 2020 40 under 40 in Health| Fortune
September 2020
Fortune
Publications
View all
Extensive germline genome engineering in pigs
September 2020
Nat Biomed Eng
RNA-guided human genome engineering via Cas9
January 2013
Science
Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9
June 2017
Science